CHC Medical Affairs, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.
Curr Drug Saf. 2023;18(1):97-102. doi: 10.2174/1574886317666220414125027.
Caffeine enhances the efficacy of non-opioid analgesics. Data on the cardiovascular health effects of caffeine intake are controversial, and studies on the cardiovascular effects of medical caffeine use are lacking.
The study aims to explore the cardiovascular effects of an ibuprofen/caffeine combination in comparison to ibuprofen alone.
Secondary analysis of a previously reported bioequivalence study of a single dose of a fixed dose ibuprofen/caffeine combination (400/100 mg) vs. ibuprofen alone in a randomized, cross-over design in 36 healthy volunteers. Plasma catecholamines were analyzed to enhance mechanistic interpretation of the data.
After exclusion of 10 protocol violators (pre-dosing intake of caffeine), vital signs were comparable over a 24-h period in the absence and presence of caffeine. Plasma catecholamine levels were also comparable.
These data do not support the hypothesis that occasional intake of a small dose of caffeine as part of pain medication imposes a health risk due to vital sign changes. Based on the proven increase in efficacy, the addition of caffeine to non-opioid analgesics such as IBU has a favorable risk/benefit profile for occasional use.
咖啡因能增强非阿片类镇痛药的疗效。关于咖啡因摄入对心血管健康影响的数据存在争议,而且缺乏关于医用咖啡因使用对心血管影响的研究。
本研究旨在探讨布洛芬/咖啡因复方与布洛芬单药相比的心血管效应。
对先前报告的一项单次固定剂量布洛芬/咖啡因复方(400/100mg)与布洛芬单药的生物等效性研究进行二次分析,该研究采用随机、交叉设计,纳入 36 例健康志愿者。为了增强对数据机制的解释,分析了血浆儿茶酚胺。
排除 10 例(预服咖啡因)方案违反者后,在无咖啡因和有咖啡因的情况下,24 小时内生命体征无差异。血浆儿茶酚胺水平也无差异。
这些数据不支持偶尔摄入小剂量咖啡因作为止痛药物的一部分会因生命体征变化而带来健康风险的假设。基于已证实的疗效增加,偶尔使用时,将咖啡因添加到非阿片类镇痛药(如 IBU)中具有有利的风险/获益比。